Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Discovery and characterization of long intergenic non-coding RNAs (lincRNA) module biomarkers in prostate cancer: an integrative analysis of RNA-Seq data.

BMC genomics - 1 Jan 2015

Cui Weirong, Qian Yulan, Zhou Xiaoke, Lin Yuxin, Jiang Junfeng, Chen Jiajia, Zhao Zhongming, Shen Bairong

Abstract excerpt

BACKGROUND: Prostate cancer (PCa) is a leading cause of cancer-related death of men worldwide. There is an urgent need to develop novel biomarkers for PCa prognosis and diagnosis in the post prostate-specific antigen era. Long intergenic noncoding RNAs (lincRNAs) play essential roles in many physiological processes and can serve as alternative biomarkers for prostate cancer, but there has been no systematic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Databases, Genetic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Principal Component Analysis

Share to Prognosis

Share to Prostatic Neoplasms

Share to RNA, Long Noncoding

Share to Sequence Analysis, RNA

Source

Open in PubMed Open full text

Identifiers

PMID: 26100580
DOI: 10.1186/1471-2164-16-S7-S3
PMCID: PMC4474418

Genes

PXN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Discovery and characterization of long intergenic non-coding RNAs (lincRNA) module biomarkers in prostate cancer: an integrative analysis of RNA-Seq data.PMID 26100580Read ↗

Non-Coding RNA Biomarkers in Prostate Cancer: Evidence Mapping and in Silico CharacterizationSemantic proximity Read ↗

Characterization and validation of long noncoding RNAs as new candidates in prostate cancerSemantic proximity Read ↗

Development and validation of a set of novel and robust 4-lncRNA-based nomogram predicting prostate cancer survival by bioinformatics analysisSemantic proximity Read ↗

Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancerSemantic proximity Read ↗

RNA modification Regulators' Co-Expression Score (RMRCoeS) predicts biochemical recurrence and therapy response in prostate cancer: A multi-omics and experimental validation study.Semantic proximity Read ↗

The evolution of long noncoding RNA acceptance in prostate cancer initiation, progression, and its clinical utility in disease managementSemantic proximity Read ↗

Integrated Multi-Omics Data Reveals the Molecular Subtypes of Prostate CancerSemantic proximity Read ↗

Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?Semantic proximity Read ↗

microRNA Dysregulation in Prostate Cancer: Network Analysis Reveals Preferential Regulation of Highly Connected NodesSemantic proximity Read ↗

Current Insights into Long Non-Coding RNAs (LncRNAs) in Prostate CancerSemantic proximity Read ↗

Long non-coding RNAs and prostate cancer.Semantic proximity Read ↗

Importance of long non-coding RNAs in the pathogenesis, diagnosis, and treatment of prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.